A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic Keratosis

NCT05279131 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Keratosis, Actinic

Interventions

DRUG: Tirbanibulin ointment 1%

Sponsor

Almirall, S.A.